Nephros (NEPH) Stock Price

Nephros Price

NASDAQ·CLOSED
3.55USD-0.08 (-2.23 %)
Market closed

Over the last 19 years Nephros grew revenue by 9.7% annually, reaching 14.16 M USD. For Nephros, the net margin of 0.5% is up versus -55.7% a few years ago. The consensus 12-month price target for Nephros is 7.14 USD, about 101.1% above where the stock trades today. Of 8 analysts, 7 rate the stock a buy — an overall Buy consensus. The stock trades about 29% above its 52-week low.

Nephros stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Nephros over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Nephros stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Nephros's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Nephros Stock Price History
DateNephros Price
7/14/20263.55 USD
7/13/20263.63 USD
7/10/20263.63 USD
7/9/20263.50 USD
7/8/20263.45 USD
7/7/20263.41 USD
7/6/20263.43 USD
7/2/20263.40 USD
7/1/20263.37 USD
6/30/20263.57 USD
6/29/20263.58 USD
6/26/20263.61 USD
6/25/20263.27 USD
6/24/20263.35 USD
6/23/20263.30 USD
6/22/20263.25 USD
6/18/20263.15 USD
6/17/20263.20 USD
6/16/20263.19 USD
6/15/20263.13 USD
6/12/20263.34 USD
6/11/20263.33 USD
6/10/20263.20 USD
6/9/20263.25 USD
6/8/20263.39 USD
6/5/20263.42 USD
6/4/20263.59 USD
6/3/20263.64 USD
6/2/20263.80 USD
6/1/20263.69 USD
5/29/20263.66 USD
5/28/20263.70 USD
5/27/20263.60 USD
5/26/20263.58 USD
5/22/20263.47 USD
5/21/20263.69 USD
5/20/20263.57 USD
5/19/20263.63 USD
5/18/20263.68 USD
5/15/20263.13 USD
5/14/20263.58 USD
5/13/20263.55 USD
5/12/20263.01 USD
5/11/20262.95 USD
5/8/20263.52 USD
5/7/20263.23 USD
5/6/20263.22 USD
5/5/20263.14 USD
5/4/20263.07 USD
5/1/20263.11 USD
4/30/20263.16 USD
4/29/20263.24 USD
4/28/20263.32 USD
4/27/20263.23 USD
4/24/20262.87 USD
4/23/20262.75 USD
4/22/20262.84 USD
4/21/20262.87 USD
4/20/20263.07 USD
4/17/20262.95 USD
4/16/20262.95 USD
4/15/20263.11 USD
4/14/20262.88 USD
4/13/20262.91 USD
4/10/20262.96 USD
4/9/20262.91 USD
4/8/20262.91 USD
4/7/20262.78 USD
4/6/20262.86 USD
4/2/20262.87 USD
4/1/20262.96 USD
3/31/20262.98 USD
3/30/20262.83 USD
3/27/20262.89 USD
3/26/20262.94 USD
3/25/20263.02 USD
3/24/20263.05 USD
3/23/20263.11 USD
3/20/20262.91 USD
3/19/20262.95 USD
3/18/20263.06 USD
3/17/20263.00 USD
3/16/20262.92 USD
3/13/20263.50 USD
3/12/20263.80 USD
3/11/20263.93 USD
3/10/20264.09 USD
3/9/20264.01 USD
3/6/20263.87 USD
3/5/20263.89 USD
3/4/20263.82 USD
3/3/20263.87 USD
3/2/20264.08 USD
2/27/20263.91 USD
2/26/20264.00 USD
2/25/20264.02 USD
2/24/20263.88 USD
2/23/20263.77 USD
2/20/20264.08 USD
2/19/20263.89 USD
2/18/20263.77 USD
2/17/20264.00 USD
2/13/20264.10 USD
2/12/20263.76 USD
2/11/20264.04 USD
2/10/20263.89 USD
2/9/20264.02 USD
2/6/20263.87 USD
2/5/20263.88 USD
2/4/20264.11 USD
2/3/20264.26 USD
2/2/20264.57 USD
1/30/20264.31 USD
1/29/20264.39 USD
1/28/20264.51 USD
1/27/20264.43 USD
1/26/20264.49 USD
1/23/20264.68 USD
1/22/20264.66 USD
1/21/20264.56 USD
1/20/20264.94 USD
1/16/20264.48 USD
1/15/20264.38 USD
1/14/20264.41 USD
1/13/20264.42 USD
1/12/20264.54 USD
1/9/20264.81 USD
1/8/20265.01 USD
1/7/20265.16 USD
1/6/20265.41 USD
1/5/20264.86 USD
1/2/20264.75 USD
12/31/20254.88 USD
12/30/20254.72 USD
12/29/20254.87 USD
12/26/20254.93 USD
12/24/20255.23 USD
12/23/20254.66 USD
12/22/20254.85 USD
12/19/20255.03 USD
12/18/20255.07 USD
12/17/20254.97 USD
12/16/20254.85 USD
12/15/20254.86 USD
12/12/20255.02 USD
12/11/20254.97 USD
12/10/20255.12 USD
12/9/20255.32 USD
12/8/20254.93 USD
12/5/20255.65 USD
12/4/20255.79 USD
12/3/20255.40 USD
12/2/20255.31 USD
12/1/20255.23 USD
11/28/20254.88 USD
11/26/20255.41 USD
11/25/20255.69 USD
11/24/20254.87 USD
11/21/20254.87 USD
11/20/20254.92 USD
11/19/20255.03 USD
11/18/20255.45 USD
11/17/20255.43 USD
11/14/20254.40 USD
11/13/20254.42 USD
11/12/20254.56 USD
11/11/20254.33 USD
11/10/20254.29 USD
11/7/20254.60 USD
11/6/20255.20 USD
11/5/20255.69 USD
11/4/20255.20 USD
11/3/20255.37 USD
10/31/20255.70 USD
10/30/20255.61 USD
10/29/20255.45 USD
10/28/20255.74 USD
10/27/20255.42 USD
10/24/20255.23 USD
10/23/20255.14 USD
10/22/20254.80 USD
10/21/20254.85 USD
10/20/20255.24 USD
10/17/20254.89 USD
10/16/20255.33 USD
10/15/20255.49 USD
10/14/20255.38 USD
10/13/20255.34 USD
10/10/20255.40 USD
10/9/20255.40 USD
10/8/20255.16 USD
10/7/20255.68 USD
10/6/20255.44 USD
10/3/20254.77 USD
10/2/20254.64 USD
10/1/20254.62 USD
9/30/20254.73 USD
9/29/20254.57 USD
9/26/20254.45 USD
9/25/20254.18 USD
9/24/20254.15 USD
9/23/20254.25 USD
9/22/20254.31 USD
9/19/20254.18 USD
9/18/20254.06 USD
9/17/20254.27 USD
9/16/20254.31 USD
9/15/20254.36 USD
9/12/20254.26 USD
9/11/20254.21 USD
9/10/20254.27 USD
9/9/20254.40 USD
9/8/20253.93 USD
9/5/20253.83 USD
9/4/20254.00 USD
9/3/20254.15 USD
9/2/20254.20 USD
8/29/20253.73 USD
8/28/20254.03 USD
8/27/20254.05 USD
8/26/20254.04 USD
8/25/20254.19 USD
8/22/20254.18 USD
8/21/20254.02 USD
8/20/20254.08 USD
8/19/20254.13 USD
8/18/20254.30 USD
8/15/20254.25 USD
8/14/20254.00 USD
8/13/20254.12 USD
8/12/20254.26 USD
8/11/20254.49 USD
8/8/20253.90 USD
8/7/20252.89 USD
8/6/20253.00 USD
8/5/20253.10 USD
8/4/20253.24 USD
8/1/20253.42 USD
7/31/20253.55 USD
7/30/20253.53 USD
7/29/20253.47 USD
7/28/20253.60 USD
7/25/20253.57 USD
7/24/20253.44 USD
7/23/20253.53 USD
7/22/20253.51 USD
7/21/20253.57 USD
7/18/20253.65 USD
7/17/20253.58 USD
7/16/20253.45 USD
Access this data via the Eulerpool API
Get Free API Key

Nephros Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
8.56 M USD
-4.28 M USD
-4.77 M USD
Jan 1, 2021
10.22 M USD
-3.25 M USD
-4.11 M USD
Jan 1, 2022
9.98 M USD
-4.34 M USD
-7.38 M USD
Jan 1, 2023
14.24 M USD
-1.59 M USD
-1.58 M USD
Jan 1, 2024
14.16 M USD
6,000.00 USD
74,000.00 USD
Jan 1, 2025 (e)
18.88 M USD
1.21 M USD
1.19 M USD
Jan 1, 2026 (e)
21.20 M USD
1.69 M USD
1.63 M USD
Jan 1, 2027 (e)
23.32 M USD
2.59 M USD
2.28 M USD

Nephros Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 16, 2026, 1:14 AM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
20122013201420152016201720182019202020212022202320242025e2026e2027e
1.001.001.001.002.003.005.0010.008.0010.009.0014.0014.0018.0021.0023.00
-50.00–––100.0050.0066.67100.00-20.0025.00-10.0055.56–28.5716.679.52
100.00800.00100.00100.0050.0066.6760.0060.0050.0050.0044.4457.1457.1457.1457.1457.14
1.008.001.001.001.002.003.006.004.005.004.008.008.0010.2912.0013.14
-3.001.00-7.00-3.00-3.00–-3.00-3.00-4.00-4.00-7.00-1.00–1.001.002.00
50.00-133.33-800.00-57.14––––33.33–75.00-85.71–––100.00
1.252.312.653.865.405.886.857.549.0810.0210.3010.3910.6010.6010.6010.60
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Nephros generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Nephros retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Nephros's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Nephros has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Nephros's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Nephros stock margins

The Nephros margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Nephros. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Nephros.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
57.36 %
-50.00 %
-55.72 %
Jan 1, 2021
55.09 %
-31.80 %
-40.22 %
Jan 1, 2022
47.39 %
-43.49 %
-73.95 %
Jan 1, 2023
59.03 %
-11.19 %
-11.06 %
Jan 1, 2024
61.59 %
0.04 %
0.52 %
Jan 1, 2025 (e)
61.59 %
6.39 %
6.32 %
Jan 1, 2026 (e)
61.59 %
7.96 %
7.67 %
Jan 1, 2027 (e)
61.59 %
11.12 %
9.76 %

Nephros Stock Revenue, EBIT, Earnings per Share

The Nephros earnings per share therefore indicates how much revenue Nephros has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
0.94 USD
-0.47 USD
-0.53 USD
Jan 1, 2021
1.02 USD
-0.32 USD
-0.41 USD
Jan 1, 2022
0.97 USD
-0.42 USD
-0.72 USD
Jan 1, 2023
1.37 USD
-0.15 USD
-0.15 USD
Jan 1, 2024
1.34 USD
0.00 USD
0.01 USD
Jan 1, 2025 (e)
1.78 USD
0.11 USD
0.11 USD
Jan 1, 2026 (e)
1.99 USD
0.16 USD
0.15 USD
Jan 1, 2027 (e)
2.19 USD
0.24 USD
0.21 USD

Nephros business model & stock analysis

Nephros Segments

Nephros Revenue by Segment (1/5)

  • 3 Years

  • 5 Years

  • Max

Product
Product Revenues
Product Revenue
Royalty And Other Revenues
License, Royalty and Other Revenues
Details
Date
Product
Product Revenues
Product Revenue
Royalty And Other Revenues
License, Royalty and Other Revenues
Jan 1, 2018
0.00 USD
0.00 USD
5.46 M USD
0.00 USD
230,000.00 USD
Jan 1, 2019
0.00 USD
10.18 M USD
0.00 USD
152,000.00 USD
0.00 USD
Jan 1, 2020
0.00 USD
8.45 M USD
0.00 USD
108,000.00 USD
0.00 USD
Jan 1, 2021
10.20 M USD
0.00 USD
0.00 USD
200,000.00 USD
0.00 USD
Jan 1, 2022
9.93 M USD
0.00 USD
0.00 USD
46,000.00 USD
0.00 USD

Nephros Revenue by Segment (2/5)

  • 3 Years

  • 5 Years

  • Max

License Royalty and Other Revenue
Royalty Revenue
Other Revenue
Details
Date
Service
License Royalty and Other Revenue
Royalty Revenue
Other Revenue
Jan 1, 2018
0.00 USD
0.00 USD
101,000.00 USD
29,000.00 USD
Jan 1, 2019
0.00 USD
0.00 USD
59,000.00 USD
77,000.00 USD
Jan 1, 2020
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
200,000.00 USD
20,000.00 USD
121,000.00 USD
Jan 1, 2022
0.00 USD
0.00 USD
0.00 USD
46,000.00 USD

Nephros Revenue by Segment (3/5)

  • 3 Years

  • 5 Years

  • Max

License Royalty and Other Revenue
Royalty Revenue
Other Revenue
Details
Date
License Royalty and Other Revenue
Royalty Revenue
Other Revenue
Jan 1, 2018
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2019
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2020
108,000.00 USD
68,000.00 USD
40,000.00 USD
Jan 1, 2021
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2022
0.00 USD
0.00 USD
0.00 USD

Nephros Revenue by Segment (4/5)

  • 3 Years

  • Max

Consolidated
Water Filtration
Pathogen Detection
Details
Date
Consolidated
Water Filtration
Pathogen Detection
Jan 1, 2018
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2019
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2020
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
10.22 M USD
187,000.00 USD
Jan 1, 2022
9.98 M USD
9.98 M USD
0.00 USD

Nephros Revenue by Segment (5/5)

  • 3 Years

  • 5 Years

  • Max

Consolidated
Water Filtration
Pathogen Detection
Details
Date
Consolidated
Water Filtration
Pathogen Detection
Jan 1, 2018
0.00 USD
5.69 M USD
0.00 USD
Jan 1, 2019
0.00 USD
10.33 M USD
0.00 USD
Jan 1, 2020
8.56 M USD
8.53 M USD
29,000.00 USD
Jan 1, 2021
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2022
0.00 USD
0.00 USD
0.00 USD

Nephros Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Nephros historical P/E ratio, EBIT multiple, and P/S ratio

Nephros annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Nephros shares outstanding

The number of shares of Nephros was 10.6 M in 2025. This indicates how many shares Nephros is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
9.08 M Stocks
Jan 1, 2021
10.02 M Stocks
Jan 1, 2022
10.30 M Stocks
Jan 1, 2023
10.39 M Stocks
Jan 1, 2024
10.60 M Stocks
Jan 1, 2025 (e)
10.60 M Stocks
Jan 1, 2026 (e)
10.60 M Stocks
Jan 1, 2027 (e)
10.60 M Stocks

Nephros stock splits

In Nephros's history, there have been no stock splits.

Current Nephros forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy87.50 % (7)
Hold12.50 % (1)
Sell0.00 % (0)
12M Price Target
7.14
Last Price
3.55
Currency
USD
12M Return Potential
101.13 %
LTM Return
0 %

Nephros Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
5/7/20260.01USD5.12 MUSD2026 Q1
5/6/20260.01USD5.12 MUSD2026 Q1
3/12/20260.01USD4.54 MUSD2025 Q4
3/5/20260.01USD4.54 MUSD2025 Q4
3/4/20260.01USD4.54 MUSD2025 Q4
11/6/2024-0.01USD4.01 MUSD2024 Q3
5/8/2024-0.03USD3.96 MUSD2024 Q1
3/6/2024-0.03USD3.89 MUSD2023 Q4
8/8/2023-0.05USD-USD2023 Q2

Nephros shareholder structure

% Name
33.94244%
Wexford Capital LP
Wexford Capital LP
4.49152%
Topline Capital Management, LLC
Topline Capital Management, LLC
3.47798%
Pessin (Sandra F)
Pessin (Sandra F)
3.23738%
Pessin (Norman H)
Pessin (Norman H)
3.04274%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
1.23350%
Bard Associates Inc.
Bard Associates Inc.

Nephros Executives and Management Board

RB

Mr. Robert Banks

(50)

President, Chief Executive Officer, Director · since 2023

Compensation410,172.00 USD
JK

Ms. Judith Krandel

(60)

Chief Financial Officer

Compensation148,704.00 USD
OS

Mr. Oliver Spandow

(53)

Independent Director

Compensation65,388.00 USD
AA

Mr. Arthur Amron

(68)

Director

Compensation49,478.00 USD
JH

Mr. Joseph Harris

(57)

Independent Director

Compensation45,524.00 USD

Nephros Supply Chain

Nephros Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
3 companies
#Name1M3M6M1Y2YTrend
1
Medtronic
Supplier
0.55
0.11
0.39
0.86
0.50
#Name1M3M6M1Y2YTrend
1
Medica
Supplier
0.65
0.02
0.73
—
—
2
Vista Outdoor
Supplier
-0.47
0.08
0.74
0.59
0.04

Frequently asked questions about Nephros

Analysts currently set an average price target of 7.14 USD for the Nephros stock (median: 7.14 USD), implying +101.1 % versus the latest price. The consensus is based on 8 analyst ratings.

Nephros Analyst Price Targets 2026

All fundamentals and in-depth analysis of Nephros

Our stock analysis for Nephros stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nephros. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Nephros Stock
Nephros Revenue→
Nephros Stock
Nephros Net Income→
Nephros Stock
Nephros P/E→
Nephros Stock
Nephros P/S→
Nephros Stock
Nephros EBIT→
Nephros Stock
Nephros Dividend→
Nephros Stock
Nephros Directors Dealings→
Nephros Stock
Nephros Stocks→
Nephros Stock
Nephros Market capitalization→
Nephros Stock
Nephros Debt→
Nephros Stock
Nephros Liabilities→
Nephros Stock
Nephros Equity→
Nephros Stock
Nephros AAQS→
Nephros Stock
Nephros Employees→
Nephros Stock
Nephros ROE→
Nephros Stock
Nephros ROA→
Nephros Stock
Nephros ROCE→
Nephros Stock
Nephros News→
Nephros Stock
Nephros Analyst Price Targets→

Cyclical consumption Stocks

NerdyNeooto CoNet A Go Technology CoNeogem IndiaNet Savings LinkNeo-Concept International Group HoldingsNetanel GroupNelly Group AB (publ)NetClass TechnologyNeinor HomesNeutech GroupNebelhornbahn-All Stocks A–Z →